IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update
IDEXX Laboratories (NASDAQ: IDXX) reported positive trends in the U.S. Companion Animal Market as of July 31, 2020. Same-store clinical visits rose by 6%, while total practice revenue increased by 10%. These metrics reflect continued growth in companion animal healthcare, signaling strong demand for IDEXX's veterinary diagnostics and software solutions. The insights were made available on IDEXX's investor relations website.
- Same-store clinical visits up by 6% in July.
- Total practice revenue increased by 10%.
- None.
WESTBROOK, Maine, Aug. 13, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, July 31st. For the month of July, U.S. same-store clinical visits increased
The U.S. Companion Animal Market Trends Snapshot is available on the IDEXX website, www.idexx.com/investors.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry, tests for the quality and safety of water and milk, and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.
Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as "expects," "may," "anticipates," "intends," "would," "will," "plans," "believes," "estimates," "should," "project," and similar words and expressions. These forward-looking statements are intended to provide our current expectation or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of some of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review IDEXX's filings with the United States Securities and Exchange Commission (which are available from the SEC's EDGAR database at sec.gov and via IDEXX's website at idexx.com).
Contact:
Media Relations
media@idexx.com
Investor Relations
John Ravis
1-207-556-8155
investor-relations@idexx.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/idexx-laboratories-provides-us-companion-animal-market-trends-update-301111414.html
SOURCE IDEXX Laboratories, Inc.
FAQ
What recent trends did IDEXX Laboratories report for the U.S. Companion Animal Market?
What is the stock symbol for IDEXX Laboratories?
When was the IDEXX Laboratories market trends update released?
Where can I find more information about IDEXX Laboratories' market trends?
